Search results
Results from the WOW.Com Content Network
The first left ventricular assist device (LVAD) system was created by Domingo Liotta at Baylor College of Medicine in Houston in 1962. The first LVAD was implanted in 1963 by Liotta and E. Stanley Crawford. The first successful implantation of an LVAD was completed in 1966 by Liotta along with Dr. Michael E. DeBakey.
Berlin Heart GmbH is a German company that develops, produces and markets ventricular assist devices (VADs). The devices mechanically support the hearts of patients with end-stage heart failure . Berlin Heart's products include the implantable INCOR VAD and the paracorporeal EXCOR VAD.
Similarly, ICD use in primary prevention is to prevent cardiac death in patients who are at risk for sustained ventricular tachycardia or ventricular fibrillation. This population accounts for the bulk of all ICD implants. There are a multitude of guideline indications for ICD use in primary preventions with varying degree of supporting evidence.
Patients who are relatively older, who need ICD for secondary prevention, or who have concomitant bradycardia requiring pacing, or heart failure requiring cardiac resynchronisation therapy are more suitable for transvenous ICD implantation. An older patient with ischemic cardiomyopathy and documented symptomatic ventricular tachycardia is a ...
In 2000, the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial was conducted. REMATCH was a multi-center study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Implantation of a cardiac resynchronization (biventricular) pulse generator with defibrillator [AICD], formation of pocket, transvenous leads, including placement of lead into left ventricular coronary venous system, intraoperative procedures for evaluation of lead signals, and obtaining defibrillator threshold measurements.
An artificial organ is a human-made organ device or tissue that is implanted or integrated into a human – interfacing with living tissue – to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. [1]